Brazilian Thoracic Society recommendations for the diagnosis and monitoring of asbestos-exposed individuals-Reference-Cited by-同舟云学术

Brazilian Thoracic Society recommendations for the diagnosis and monitoring of asbestos-exposed individuals

Published:2024-06-23 Issue: Volume: Page:e20240156
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

Paula Santos1 Ubiratan¹,Algranti2 Eduardo²,Mello De Capitani3 Eduardo³,Faibischew Prado4 Gustavo⁴,Scalia Carneiro5 Ana Paula⁵,Sousa Rodrigues6 Sílvia Carla⁶,Benedito Pires de Freitas1,7 Jefferson⁷,Caruso Chate8,9 Rodrigo⁸,Futoshi Mizutani1 Rafael¹,Albuquerque de Castro10 Hermano⁹,Abdo Arbex11 Marcos¹⁰,Canto Ribeiro12 Patrícia¹¹,Nunes Tietboehl Filho13 Carlos¹²,Cruz de Oliveira Castellano6 Maria Vera⁶,Ward Leite1 Guilherme¹,Corrêa de Almeida14 Gustavo¹³,Occupational Diseases Committee on Environmental and¹⁴

Affiliation:

1. 1. Grupo de Doenças Respiratórias Ocupacionais, Ambientais e de Cessação de Tabagismo, Divisão de Pneumologia, Instituto do Coracao – InCor – Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo – FMUSP – Sao Paulo (SP) Brasil.

2. 2. Fundação Jorge Duprat Figueiredo de Segurança e Medicina do Trabalho – FUNDACENTRO – São Paulo (SP) Brasil.

3. 3. Disciplina de Pneumologia e Centro de informação e Assistência Toxicológica – CIATox – Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas – UNICAMP – Campinas (SP) Brasil.

4. 4. Hospital Alemão Oswaldo Cruz, São Paulo (SP) Brasil.

5. 5. Ambulatório de Pneumologia Ocupacional do SEST, Hospital das Clínicas, Universidade Federal de Minas Gerais – UFMG – Belo Horizonte (MG) Brasil.

6. 6. Serviço de Pneumologia, Hospital do Servidor Público Estadual Francisco Morato Oliveira (HSPE-FMO)/Instituto de Assistência Médica ao Servidor Público Estadual – IAMSPE – de São Paulo, São Paulo (SP) Brasil.

7. 1. Grupo de Doenças Respiratórias Ocupacionais, Ambientais e de Cessação de Tabagismo, Divisão de Pneumologia, Instituto do Coracao – InCor – Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo – FMUSP – Sao Paulo (SP) Brasil. 7. Departamento de Saúde Coletiva, Faculdade de Ciências Médicas da Santa Casa de São Paulo – FCMSCSP – São Paulo (SP) Brasil.

8. 8. Serviço de Radiologia, Instituto do Coracao – InCor – Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo – FMUSP – Sao Paulo (SP) Brasil. 9. Hospital Israelita Albert Einstein, São Paulo (SP) Brasil.

9. 10. Fundação Oswaldo Cruz – Fiocruz – Rio de Janeiro (RJ) Brasil.

10. 11. Área Temática Pneumologia, Faculdade de Medicina, Universidade de Araraquara, Araraquara (SP) Brasil.

11. 12. Atenção à saúde da Vice-Presidência de Ambiente Atenção e Promoção da Saúde, Fundação Oswaldo Cruz – Fiocruz – Rio de Janeiro (RJ) Brasil.

12. 13. Secretaria da Saúde do Estado do Rio Grande do Sul, Porto Alegre (RS) Brasil.

13. 14. Hospital de Base, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto (SP) Brasil.

14. .

Abstract

Asbestos was largely used in Brazil. It is a mineral that induces pleural and pulmonary fibrosis, and it is a potent carcinogen. Our objective was to develop recommendations for the performance of adequate imaging tests for screening asbestos-related diseases. We searched peer-reviewed publications, national and international technical documents, and specialists' opinions on the theme. Based on that, the major recommendations are: Individuals exposed to asbestos at the workplace for = 1 year or those with a history of environmental exposure for at least 5 years, all of those with a latency period > 20 years from the date of initial exposure, should initially undego HRCT of the chest for investigation. Individuals with pleural disease and/or asbestosis should be considered for regular lung cancer monitoring. Risk calculators should be adopted for lung cancer screening, with a risk estimate of 1.5%.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference61 articles.

1. 1. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med. 2003;34(9):1117-1129. https://doi.org/10.1016/S0891-5849(03)00060-1

2. 2. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691-715. https://doi.org/10.1164/rccm.200310-1436ST

3. 3. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5-15. https://doi.org/10.5271/sjweh.3462

4. 4. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-1249. https://doi.org/10.1016/S0140-6736(20)30752-2

5. 5. Magnani C, Dalmasso P, Biggeri A, Ivaldi C, Mirabelli D, Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect. 2001;109(9):915-919. https://doi.org/10.1289/ehp.01109915